Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Designing nanostructured lipid carriers modified with folate-conjugated chitosan for targeted delivery of osthole to HT-29 colon cancer cells: investigation of anticancer, antioxidant, and antibacterial activities

Fig. 4

Caspase-3, BAX, and Bcl-2 expression profiles in HT-29 cells following treatment with 65 and 115 µg/mL of OST-NCF-NPs in comparison to control. All reported values are the mean standard deviation derived from three separate experiments (N = 3). The ‘**’ corresponds to the P-values of 0.01 and 0.01, respectively. OST-NCF-NPs Nanostructured lipid carriers coated with chitosan conjugated folate nanoparticles containing Osthole, qPCR Real-time PCR

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us